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Abstract
Background: To assess the associations of depression with glycemic control and compliance to self-care activities
in adult patients with Type 2 Diabetes Mellitus
Methods: This cross-sectional study was conducted at a tertiary-care hospital in Karachi (Aga Khan University
Hospital). Equal numbers of depressed and non-depressed patients were consecutively recruited from the diabetic
clinic. Information on demographic and clinical characteristics was collected in face-to-face interviews and from
medical records. Hospital Anxiety Depression Scale (HADS) was used to measure depression. Associations of
depressed status (HADS ≥ 8) with poor glycemic control (Hemoglobin A1c level ≥ 7%) and compliance to self-care
activities were assessed by logistic regression analyses.
Results: A total of 286 patients were included in this study with a male-female ratio of 1.2:1. Mean age was
52 years and in 64.7% of them, the duration of diabetes was more than 3 years. Depressed patients were more
likely to be female (adjusted odds ratio [OR] = 1.88; 95% confidence interval [95%CI] = 1.07-3.31), had a family
history of diabetes (OR = 2.64; 95%CI = 1.26-5.55), and poor glycemic control (OR = 5.57; 95%CI = 2.88-10.76)
compared with non-depressed patients. Depression was also associated with low compliance to self-care activities
such as taking dose as advised (OR = 0.32; 95%CI = 0.14-0.73), dietary restrictions (OR = 0.45; 95%CI = 0.26-0.79)
and foot care (OR = 0.38; 95%CI = 0.18-0.83).
Conclusions: Adult patients with Type 2 Diabetes who have depression were more likely to have poor glycemic
control and lower compliance to self-care activities, and they might need particular attention during follow-up
visits.
Background
Diabetes and obesity are now seen as a global epidemic;
with high figures from South Asia [1]. The World
Health Organization has estimated that in 2030, half of
the 333 million people living with diabetes will be from
Asia alone [2]. Pakistan is an Asian country bordering
the Arabian Sea with a population of over 176 million
as estimated in July 2009 [3]. The epidemic of diabetes
is particularly relevant to Pakistan. Surveys from differ-
ent parts of the country have estimated a prevalence of
6% in men and 3.5% in women living in urban areas [4].
Self-care is critical to outcome of diabetes and
includes compliance to medication, diet modifications,
and regular exercise [5]. If any of these are compro-
mised, the target glycemic control may not be achieved
[6,7]. Studies of the diabetic population in Pakistan
showed that more than two-thirds of investigated sam-
ples had poor glycemic control [8-10]. Reasons for these
treatment outcomes have not been investigated before.
The international research showed that depression was
associated with poor compliance to treatment [11-13].
In particular, depressed mood in diabetic patients might
lead to pessimism regarding perceived benefits and low-
ered self-efficacy, and could result in poor self-care and
compliance [14]. Furthermore, it was clearly indicated
that depression in Type 2 Diabetic patients could
severely impact management of diabetes through a
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impairment [15], poorer glycemic control [16], and
more diabetic complications [17,18]. Finally, the course
of depression is also more chronic and severe in people
with diabetes [19].
A systematic review of mental health studies from
Pakistan showed that mean overall prevalence of anxiety
and depressive disorders in the community population
was 34% [20]. Considering this high prevalence of
depression in Pakistani population, its influence on
treatment outcomes of chronic medical conditions has
rarely been investigated [10,20]. In this study we
assessed if any associations existed between depression,
glycemic control, and compliance with self-care activ-
ities in the patients attending diabetic clinics in Pakistan.
Methods
Setting
The Aga Khan University Hospital is a 500-bedded ter-
tiary care hospital that caters mostly to middle and
upper socio-economic strata. This study was conducted
in the specialist endocrine clinics. The American Dia-
betic Association (ADA) recommendations of diet, exer-
cise, glycemic monitoring, and investigations are
followed on all patients [5]. A nurse specially trained in
teaching methods of self-care (monitoring blood glu-
cose, administration of insulin, timings of medicines,
diet, and exercise suggestions) is employed at the clinic
and sees all patients.
Study design
The study was conducted from August 2008 to June
2009. All consecutive patients having type 2 diabetes
and its related complications between 18 and 60 years
of age who had at least 2 clinic visits for management of
diabetes mellitus were selected. Exclusion Criteria were
those having history of psychiatric illnesses other than
depression, and who were currently on anti-depressant
treatment and/or those who had history of use of psy-
chotropic drugs. Equal numbers of depressed and non-
depressed patients were consecutively included in this
comparative cross-sectional study. The sample size was
calculated for each group to be 143; keeping beta error
at 0.2, significance level 0.05 and with the percentage
difference in poor glycemic control between the groups
assumed to be 17% as determined in a systematic review
by Lustman and colleagues [21].
Measures
Nursing assessment was performed for each participant
that included recording of blood pressure, height and
weight. After an informed consent, a semi-structured
clinical interview was performed by the main investiga-
tor before each participant’s consultation with the
endocrinologist. Privacy was maintained throughout the
interview. Details of each participant’sd e m o g r a p h i c s ,
history of psychiatric illness/exposure to psychotropic
medications, family history of diabetes/depression, and
compliance to self-care activities were recorded.
Medical records were examined for presence of dia-
betes-related complications; renal ( “proteinuria”, “microal-
buminuria” and “renal failure”), ophthalmic ("retinopathic
changes” and “cataract”), neurological ("stroke” or “transi-
ent ischemic attack”), dyslipidemia ("Deranged lipids”),
cardiac ("Angina” or “myocardial infarction”), hyperten-
sion, arthropathies ("Charcot joints” or “diabetes-related
joint problem”), and neuropathies.
Depression was assessed using the 7-item depression
subscale of Hospital Anxiety Depression Scale (HADS)
[22]. HADS is a widely used scale validated in the local
language (Urdu) with good sensitivity and specificity
[23]. Somatic symptoms of depression (e.g. insomnia
and weight loss) are not part of this scale and therefore
findings were not confounded by symptoms of uncon-
trolled diabetes. A summative score is calculated (range
0-21) with cut-off point for depression at 8 [24].
Glycosylated Hemoglobin (HbA1c) was used as a mea-
sure of glycemic control (<7% good compliance; ≥7%
poor compliance). The sample HbA1c level was mea-
sured within next 6 months by using few drops of blood
on High-Performance Liquid Chromatography (HPLC).
It is accepted as the best measure and is used to guide
clinical management [5].
Compliance to self-care activities was measured using
a self-report technique inquiring on treatment (timing/
dosing), diet, exercise, and care of feet. Each participant
was asked about each self-care activity with the follow-
ing question in Urdu: “What percentage of the time do
you think you have followed the doctor’s recommenda-
tions?” Compliance was recorded as “poor” if their reply
w a sl e s st h a n5 0 %o ft h et i m ea n d“good” if it was 50%
or more. Study methods were approved from the Aga
Khan University Ethics Research Committee.
Statistical analysis
Frequencies of all demographic and clinical variables
were computed to identify sample characteristics. Body
Mass Index (BMI) was computed using standard for-
mula. Quantitative variables such as age, duration of ill-
ness, and BMI were regrouped in three equally
distributed categories. Associations of above mentioned
variables with depressed status (HADS ≥ 8) and glyce-
mic control were assessed using chi-square or t-test.
Further, a multivariate logistic regression model was
constructed including all significantly associated vari-
ables (P < 0.05) with backward selection strategy. Statis-
tical Package for Social Sciences Version 15.0 was used
for these analyses.
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Information on all participants (N = 286) was available.
The proportion of women (N = 158, 55.2%) in study
sample was slightly more than men (N = 128, 44.8%),
and depression was significantly higher in women than
men (60.8% vs. 39.2%; P = 0.03). All participants were
aged between 31 to 60 years. Majority (81.1%) of them
had a family history of diabetes. Family history of
depression was reported by 26.2% of them with no dif-
ference between genders. One in five patients (N = 60,
21.0%) was currently smoking cigarettes; most were men
(N = 47, 78.3%). Over two-third of patients (N = 205,
71.6%) had poor glycemic control.
Mean BMI value was 29.6 kg/m
2, (Standard deviation
[SD] = 4.7). Women had significantly higher BMI values
than men (30.4 kg/m
2,S D=5 . 2v s .2 8 . 6k g / m
2,S D=
3.8; P = <0.01). BMI was significantly higher in those
with poor glycemic control (29.2 kg/m
2 vs. 27.2 kg/m
2;
P < 0.01).
Majority (93.7%) of the patients were on oral hypogly-
cemic agents; 63.3% on monotherapy and a further
30.4% on combination with insulin. Poor glycemic con-
trol was significantly higher in patients on insulin and
combination therapy than those on oral hypoglycemics
only (86.6% vs. 63.0%; P < 0.01). Most patients (64.7%)
had duration of illness of more than three years. Those
with poor glycemic control had significantly longer
duration of diabetes (8.2 vs. 6.1 years; P< 0.01). Almost
four out of five patients (N = 234, 81.8%) had a dia-
betes-related complication. Over half of the patients
practiced self-care activities except exercise, followed by
only 28.0% of them, and women significantly less than
men (22.2% vs. 35.2%; P = 0.02). Those with poor glyce-
mic control were following exercise recommendations
significantly less than those with good glycemic control
(24.4% vs. 37.0%; P = 0.03).
Depressed patients reported more family history of
depression (32.2% vs. 20.3%) and diabetes (88.8% vs.
73.4%) than non-depressed patients. Similarly, more
depressed patients reported a diabetes-related complica-
tion than non-depressed patients (87.0% vs. 77.0%; P =
0.03). Monotherapy was significantly higher in the
depressed group (62.9% vs. 37.1%; P = 0.02) compared
with non-depressed patients.
Being a female and a family history of diabetes was
significantly associated with depression (Table 1). Simi-
larly, depressed patients were more likely to have poor
glycemic control than non-depressed patients. The
mean HbA1c level was significantly higher in depressed
than non-depressed patients (8.5% vs. 7.7%; p < 0.001).
Moreover, depressed patients were more likely to not to
take dose as advised, follow dietary restrictions, or per-
form foot care as compared with non-depressed
patients.
Discussion
Results of this study clearly showed that depression was
associated with poor treatment outcomes in included
patients. For instance, depressed patients had signifi-
cantly poorer glycemic control than non-depressed
patients. Results further indicated that this poor out-
come could be explained by lower compliance to the
recommended self-care activities such as taking dose on
time, dietary restrictions, and foot care.
Before data collection of this study, we found only two
studies from Pakistan that assessed mental health of dia-
betic patients. Both studies compared diabetic patients
and with non-diabetic controls, and included 50 or
fewer patients in each group [25,26]. Depression was
found in greater proportion in the diabetic groups than
non diabetics in both studies. A recent study by
Khuwaja et al (2010) showed that 43.5% of patients
attending diabetic clinics in Karachi had depression [27].
The study further indicated that blood pressure, fasting
blood sugar, triglycerides, and BMI were associated with
depression. However, measures of glycemic control and
compliance to self-care activities were not included in
that study. Our results clearly pointed out that informa-
tion of treatment outcomes in depressed diabetic
patients might help clinicians to better monitor such
patients.
Our sample contained mostly patients with long dura-
tion of illness, diabetes-related complications, and less
than half following self-care activities recommended by
their endocrinologist. Results showed that majority of
them had poor glycemic control which was consistent
with previous findings in Pakistan showing that 78% of
the diabetic patients had poor glycemic control [28].
The higher likelihood of poor glycemic control in the
depressed patients than non-depressed patients as indi-
cated in this study was consistent with findings from
other international studies [21,29]. Moreover, our study
indicated that depression was higher in patients with
diabetes-related complications such as renal, cerebrovas-
cular, cardiac and neuropathic and ophthalmic [30]. The
possible explanation for above findings might be that
the depression and psychological stress increase sympa-
thetic nervous system activity, inflammatory, and plate-
let aggregation, and decrease insulin sensitivity, thereby
contributing to poor glycemic control and increasing
the risk of complications [31,32]. This suggested that
regular evaluations of depression and glycemic control
might be needed in diabetic clinics.
In our study, female gender was significantly asso-
ciated with depression. It was previously shown that
female gender was associated with depression in Type 2
Diabetes [33,34]. In a meta-analysis by De Groot et al,
the combined prevalence of depression was significantly
higher in Type 2 diabetic women than Type 2 diabetic
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less likely to follow recommendations of exercise and
more likely to have greater BMI values. This suggested
that women patients with Type 2 Diabetes Mellitus
deserve special clinical attention in terms of ensuring
that lifestyle changes were adopted by them.
Our study showed that depressed patients were less
likely to follow necessary treatment recommendations
such as taking proper doses, dietary restrictions, regular
exercise, and foot care. Regression removed exercise
from the final model however, other associations
remained significant. This was consistent with previous
findings of Lin et al showing that depression was asso-
ciated with less physical activity, unhealthy diet, and low
adherence to oral hypoglycemic, anti-hypertensive, and
lipid-lowering medicines [12]. Another prospective
cohort study showed that depression could predict
lower medication adherence as well as adherence to
dietary recommendations and exercise [35]. This sug-
gested that more robust monitoring of depressed
Table 1 Characteristics of patients presenting to endocrine clinic at the Aga Khan Hospital of Karachi (N = 286)
Depressed Not depressed P Adjusted Odds ratio 95% CI
N% N %
Gender 0.03
- Men 56 39.2 72 50.3
- Women 87 60.8 71 49.7 1.88 1.07-3.31
Age (y) 0.92
- 31-47 41 28.7 44 30.8
- 48-56 54 37.8 53 37.1
- 57-60 48 33.6 46 32.2
Family history: depression 46 32.2 29 20.3 0.02
Family history: diabetes 127 88.8 105 73.4 0.01 2.64 1.26-5.55
Smoker 35 24.5 25 17.5 0.15
Body Mass Index (kg/m²) 0.02
- 18-<25 11 7.7 26 18.2
- 25 - <30 70 49.0 68 47.6
- >30 62 43.4 49 34.3
Duration of illness (y) 0.04
- 0-3 42 29.4 59 41.3
- 4-10 62 43.4 43 30.1
- >10 39 27.3 41 28.7
Complications
- Renal 37 25.9 20 14.0 0.01
- Ophthalmic 37 25.9 23 16.1 0.04
- Cerebrovascular 22 15.4 6 4.2 0.001
- Hypertension 9 6.3 10 7.0 0.81
- Dyslipidemia 89 62.2 84 58.7 0.55
- Cardiac 35 24.5 19 13.3 0.01
- Arthropathies 17 11.9 12 8.4 0.33
- Neuropathies 43 30.1 30 21.0 0.08
Treatment 0.04
- Oral hypoglycemic 81 56.6 100 69.9
- Insulin 9 6.3 9 6.3
- Insulin & oral hypoglycemic 53 37.1 34 23.8
Compliance of self care activities*
- Taking dose on time 115 80.4 125 87.4 0.11
- Taking dose as advised 105 73.4 132 92.3 0.01 0.32 0.14-0.73
- Dietary restrictions 74 51.7 101 70.6 0.01 0.45 0.26-0.79
- Exercise 28 19.6 52 36.4 0.002
- Foot care 105 73.4 129 90.2 <0.001 0.38 0.18-0.83
Poor glycemic control (Hb1Ac ≥ 7) 124 86.7 81 56.6 <0.001 5.57 2.88-10.76
*Following recommendations 50% or more of the time.
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their family members in the process of care [36].
This study has several limitations. Firstly, the cross-
sectional design is not without limitation since causality
cannot be established. Although it may be argued that
the possibility of selective loss of follow-up or non-
random treatment changes is eliminated in such a
design. Secondly, educational status and household
income were not measured in this study although they
have associations with both depression and diabetic
patients with depression [35]. However participants can
be considered to belong to middle or upper-middle
socio-economic strata as they are coming to a specialty
clinic and medical expenses are mostly borne out of
pocket in Pakistan. Thirdly, self-report was used as a
measure for self-care activities as no scale is validated in
our population. Nevertheless, this method is highly sen-
sitive to detection of non-adherence to medicines [38].
Lastly, generalization of study findings would require
similar studies in other settings in Pakistan.
In conclusion, this study suggested that patients with
type 2 diabetes should be screened for depressive symp-
toms, poor glycemic control, and non-compliance to
self-care activities. Further, women and those who had
a family history of diabetes should be closely watched
for depressive symptoms. Finally, developing a valid
instrument to measure compliance to self-care activities
might be required to improve care in Pakistani diabetic
clinics.
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